Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad
about
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky GutMetagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteriaRole of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.Inflammatory bowel disease in the dog: differences and similarities with humans.Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population.A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation.Importance of intestinal microenvironment in development of arthritis. A systematic review.Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.Changes to the Intestinal Microbiome With Parenteral Nutrition: Review of a Murine Model and Potential Clinical Implications.Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function.Total parenteral nutrition-associated lamina propria inflammation in mice is mediated by a MyD88-dependent mechanism.Association of Vitamin D Status and Clinical Outcome in Dogs with a Chronic EnteropathyMetabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease.Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases.Vam3, a Compound Derived from Vitis amurensis Rupr., Attenuated Colitis-Related Tumorigenesis by Inhibiting NF-κB Signaling Pathway.Microbes, intestinal inflammation and probiotics.Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases.Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis.Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infectionClaudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling.Epithelial apoptosis: cause or consequence of ulcerative colitis?Lactobacillus reuteri ZJ617 maintains intestinal integrity via regulating tight junction, autophagy and apoptosis in mice challenged with lipopolysaccharide.Erbin exerts a protective effect against inflammatory bowel disease by suppressing autophagic cell death.Structural modification of the gastrointestinal epithelium during immune-dependent granulomatosis.
P2860
Q28081848-0EBA93D9-1CF8-4BE7-90AC-9551C01A9A1CQ28646298-3BA3D26A-CDD7-4493-A293-0545560DAA85Q33680841-9EEC7B02-D4B3-4BA8-A639-A215BB6E03F8Q33716262-BD991EAD-3AF6-4E68-88DC-0419B34998E9Q33780207-E23705DA-F4D8-4159-AD9B-FFC3FE47AE7CQ34359061-0BA07BAD-562E-4F49-B749-2AEBA68DAB1AQ34553267-285FBA9C-29A8-4A23-88E2-387BA775152AQ35083579-F0052B68-B76B-4D4B-A315-30A8BA64DA88Q35434475-E9CB17B0-E25A-40D9-AC76-D0B6C83FB194Q35580084-F7C50418-071D-499A-AFBC-B349E9188307Q35586236-8C59A69D-31FA-4ADC-8E9A-D43A19199C9DQ35794573-C8844267-47C2-421B-A01E-26B58DF9DC53Q36055022-D63C66EF-2D12-4FF9-AC40-0C43D4A29464Q36920028-39E78BB7-0FDB-4442-A0FE-84F692F3B059Q36975601-DAF6FB8E-1704-4A99-A254-8C10B17C1F8EQ36997228-8AB064E5-BE75-41CF-B037-10097CB2E2C9Q37070484-4BA348DB-0CA9-4260-846F-CD815B510AE3Q37250270-270F0162-ECE4-48C1-9812-006A5943042DQ37965684-15A3305A-ECB3-4D53-A1D7-E6B66E0C6515Q38001400-EAA032C1-D523-4B23-AAA4-2370819912F0Q39733524-64BF64F2-D062-433C-AA7F-0FABB56AF4E1Q41823445-6C327D93-3EE9-41B5-ADB9-054195EC2A42Q42722489-809791E4-2020-4D02-A385-FDBA9659984DQ43230889-FB536CE5-E813-4237-AF71-9D0A70F303EDQ47106518-A73B3416-DBB3-4FB5-B661-3EE5784E03AEQ52649610-9BD40011-119A-4DC6-B530-746265385A17Q53190413-A6436D8F-9262-4D2B-8995-33DDD88A26CE
P2860
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad
@en
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.
@nl
type
label
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad
@en
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.
@nl
prefLabel
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad
@en
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.
@nl
P2860
P356
P1476
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad
@en
P2093
Laura P Hale
Maciej Chichlowski
P2860
P304
P356
10.1152/AJPGI.90516.2008
P577
2008-10-16T00:00:00Z